BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 25827221)

  • 1. Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion.
    Rijken JA; Niemeijer ND; Corssmit EP; Jonker MA; Leemans CR; Menko FH; Hensen EF
    Clin Genet; 2016 Jan; 89(1):128-32. PubMed ID: 25827221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma.
    Jafri M; Whitworth J; Rattenberry E; Vialard L; Kilby G; Kumar AV; Izatt L; Lalloo F; Brennan P; Cook J; Morrison PJ; Canham N; Armstrong R; Brewer C; Tomkins S; Donaldson A; Barwell J; Cole TR; Atkinson AB; Aylwin S; Ball SG; Srirangalingam U; Chew SL; Evans DG; Hodgson SV; Irving R; Woodward E; Macdonald F; Maher ER
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):898-906. PubMed ID: 23072324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma.
    Dwight T; Na U; Kim E; Zhu Y; Richardson AL; Robinson BG; Tucker KM; Gill AJ; Benn DE; Clifton-Bligh RJ; Winge DR
    BMC Cancer; 2017 Jul; 17(1):497. PubMed ID: 28738844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline
    Alzahrani AS; Bin Nafisah A; Alswailem M; Moria Y; Poprawski D; Al-Hindi H; Pacak K
    Front Endocrinol (Lausanne); 2023; 14():1273093. PubMed ID: 38152133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research progress on the pathogenesis of the SDHB mutation and related diseases.
    Liu C; Zhou D; Yang K; Xu N; Peng J; Zhu Z
    Biomed Pharmacother; 2023 Nov; 167():115500. PubMed ID: 37734265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-phenotype associations in paragangliomas of the temporal bone in a multi-ethnic cohort.
    Angeli SI; Chiossone K JA; Goncalves S; Telischi FF
    Acta Otolaryngol; 2023; 143(7):551-557. PubMed ID: 37354038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distortion in transmission of pathogenic SDHB- and SDHD-mutated alleles from parent to offspring.
    Davidoff DF; Lim ES; Benn DE; Subramaniam Y; Dorman E; Burgess JR; Akker SA; Clifton-Bligh RJ
    Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36786389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGL4 syndrome in a patient with synchronous paraganglioma-pheochromocytoma.
    Roque JJN; Martins C; Bugalho MJGM
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35351744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robotic Resection in Succinate Dehydrogenase Subunit B (SDHB)-Mutated Hereditary Paraganglioma: A Case Report of Two Patients and A Literature Review.
    Baron E; Wu CC; Gupta K; Wernberg JA; Sheehan MT; Sharma R
    Cureus; 2024 Mar; 16(3):e56336. PubMed ID: 38633941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of SDHB pathogenic variant carriers: A systematic review and meta-analysis.
    Davidoff DF; De Abreu Lourenco R; Tsang VHM; Benn DE; Clifton-Bligh RJ
    J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38605204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine-Secreting Carotid Body Paraganglioma in a Patient With SDHB Mutation.
    Mustafa K; Zadeh S; Culver SA
    AACE Clin Case Rep; 2024; 10(3):109-112. PubMed ID: 38799041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genealogical tree study in patients with familial paraganglioma syndrome due to SDHD mutation.
    López Montalbán Á; Simón Frapolli VJ; Picón César MJ
    Med Clin (Barc); 2024 Mar; 162(6):306-307. PubMed ID: 38042737
    [No Abstract]   [Full Text] [Related]  

  • 13. Genotype-phenotype correlations in paediatric and adolescent phaeochromocytoma and paraganglioma: a cross-sectional study.
    Seabrook A; Vasudevan A; Neville K; Gerstl B; Benn D; Smith J; Kirk J; Gill A; Clifton-Bligh R; Tucker K
    Arch Dis Child; 2024 Feb; 109(3):201-208. PubMed ID: 38071512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical picture: SDHD paraganglioma presenting with syncope.
    LaChance DP; Hoang TD; Shakir MKM
    Clin Case Rep; 2021 Feb; 9(2):1031-1032. PubMed ID: 33598293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced penetrance in hereditary movement disorders.
    Klein C; Kaiser F
    Med Genet; 2022 Jun; 34(2):95. PubMed ID: 38835913
    [No Abstract]   [Full Text] [Related]  

  • 16. Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.
    Luchetti A; Walsh D; Rodger F; Clark G; Martin T; Irving R; Sanna M; Yao M; Robledo M; Neumann HP; Woodward ER; Latif F; Abbs S; Martin H; Maher ER
    Int J Endocrinol; 2015; 2015():138573. PubMed ID: 25883647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional consequences of succinate dehydrogenase subunit B mutations.
    Kim E; Rath EM; Tsang VH; Duff AP; Robinson BG; Church WB; Benn DE; Dwight T; Clifton-Bligh RJ
    Endocr Relat Cancer; 2015 Jun; 22(3):387-97. PubMed ID: 25972245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY.
    Turkova H; Prodanov T; Maly M; Martucci V; Adams K; Widimsky J; Chen CC; Ling A; Kebebew E; Stratakis CA; Fojo T; Pacak K
    Endocr Pract; 2016 Mar; 22(3):302-14. PubMed ID: 26523625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Additional Value of Somatostatin Receptor Positron Emission Computed Tomography ([
    de Bresser CJM; Petri BJ; Braat AJAT; de Keizer B; van Treijen MJC; Dankbaar JW; Pameijer FA; Kok MGJ; de Ridder M; van Nesselrooij BPM; de Bree R; de Borst GJ; Rijken JA
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.
    Taïeb D; Nölting S; Perrier ND; Fassnacht M; Carrasquillo JA; Grossman AB; Clifton-Bligh R; Wanna GB; Schwam ZG; Amar L; Bourdeau I; Casey RT; Crona J; Deal CL; Del Rivero J; Duh QY; Eisenhofer G; Fojo T; Ghayee HK; Gimenez-Roqueplo AP; Gill AJ; Hicks R; Imperiale A; Jha A; Kerstens MN; de Krijger RR; Lacroix A; Lazurova I; Lin FI; Lussey-Lepoutre C; Maher ER; Mete O; Naruse M; Nilubol N; Robledo M; Sebag F; Shah NS; Tanabe A; Thompson GB; Timmers HJLM; Widimsky J; Young WJ; Meuter L; Lenders JWM; Pacak K
    Nat Rev Endocrinol; 2024 Mar; 20(3):168-184. PubMed ID: 38097671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.